John L Law

Title: John L Law: Innovator in Hepatitis C Research

Introduction

John L Law is a prominent inventor based in Edmonton, Canada. He has made significant contributions to the field of medical research, particularly in the development of immunogenic compositions for the hepatitis C virus. With a total of 12 patents to his name, Law's work has the potential to impact the treatment and prevention of hepatitis C.

Latest Patents

Among his latest patents, Law has developed immunogenic compositions that include a hepatitis C virus (HCV) heterodimeric polypeptide comprising HCV E1 and E2 polypeptides. These compositions aim to induce an immune response in individuals against HCV. Additionally, he has worked on affinity tagged heterodimeric polypeptides that facilitate the production of HCV E1/E2 heterodimers, which are crucial for advancing vaccine development.

Career Highlights

Law has had a distinguished career, working with esteemed institutions such as the University of Alberta and the Helmholtz Center for Infection Research. His research has focused on innovative methods to combat hepatitis C, showcasing his dedication to improving public health through scientific advancements.

Collaborations

Throughout his career, Law has collaborated with notable scientists, including Michael Houghton and Michael Logan. These partnerships have further enriched his research and contributed to the development of effective solutions for hepatitis C.

Conclusion

John L Law's innovative work in hepatitis C research exemplifies the impact of dedicated inventors in the medical field. His contributions continue to pave the way for advancements in treatment and prevention strategies.